Keith Greenawalt

Title: Innovations by Keith Greenawalt in Hemostatic Technologies

Introduction

Keith Greenawalt is an accomplished inventor based in Milton, MA, known for his significant contributions to the field of hemostatic technologies. With a total of three patents to his name, Greenawalt has focused on developing innovative solutions that address critical medical needs.

Latest Patents

Among his latest patents is a flowable hemostatic suspension, which describes compositions and methods related to flowable hemostats that crosslink during and/or after application to a bleeding site. Another notable patent involves reactive dry powdered hemostatic materials that comprise a protein and a multifunctionalized modified polyethylene glycol-based crosslinking agent. This invention outlines compositions that can act as hemostats when applied in dry powder form to a bleeding wound, where the components crosslink to form a hydrogel.

Career Highlights

Greenawalt's career is marked by his role at Davol Inc., where he has been instrumental in advancing hemostatic technologies. His work has not only contributed to the medical field but has also paved the way for new treatment options for patients experiencing severe bleeding.

Collaborations

Throughout his career, Greenawalt has collaborated with notable professionals, including Frederick H Strickler, Jr. and Christopher Bowley. These collaborations have enhanced the development of his innovative solutions and have contributed to the success of his projects.

Conclusion

Keith Greenawalt's work in hemostatic technologies exemplifies the impact of innovation in the medical field. His patents reflect a commitment to improving patient care through advanced medical solutions.